Eyenovia, Inc. - Common Stock (NQ:EYEN)

15.82 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 2, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eyenovia, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Porch Group And 2 Other Stocks Under $3 Insiders Are Buying ↗

September 20, 2023

The Dow Jones closed lower by over 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Earnings Preview For Eyenovia ↗

August 09, 2023

Via Benzinga

Glancy Prongay & Murray LLP Announces Investigation of Eyenovia, Inc. (EYEN)

June 15, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

Eyenovia Expands Its US Manufacturing Capabilities

June 06, 2023

Via ACCESSWIRE

Eyenovia, Inc. (NASDAQ:EYEN) Investor Notice: Investigation over Possible Securities Laws Violations ↗

May 24, 2023

San Diego, CA -- (SBWIRE) -- 05/24/2023 -- An investigation was announced for investors of Eyenovia, Inc. (NASDAQ:EYEN) shares over potential securities laws violations by Eyenovia, Inc.

Via SBWire

Recap: Eyenovia Q1 Earnings ↗

May 11, 2023

Via Benzinga

A Preview Of Eyenovia's Earnings ↗

May 10, 2023

Via Benzinga

Eyenovia Inc. (NASDAQ: EYEN) Records 52-Week High Tuesday Morning

April 04, 2023

Via Investor Brand Network

Preview: Eyenovia's Earnings ↗

March 29, 2023

Via Benzinga

HC Wainwright Initiates This Eye-Focused Stock With Almost 400% Upside ↗

October 05, 2022

Via Benzinga

Eyenovia Shares Dip Despite FDA Approving Its First Product ↗

May 08, 2023

The FDA approved Eyenovia Inc's (NASDAQ: EYEN) Mydcombi (tropicamide and phenylephrine hydrochloride ophthalmic spray) 1%/2.5% for inducing mydriasis for diagnostic procedures and in conditions where...

Via Benzinga

Glancy Prongay & Murray LLP Announces Investigation of Eyenovia, Inc. (EYEN)

May 08, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

Top 5 Health Care Stocks That May Fall Off A Cliff This Quarter ↗

April 17, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Eyenovia Showcases Microdose Array Print (MAP™) Technology at CES 2023 in Las Vegas

January 31, 2023

In the Digital Health and Startups category at the 2023 Consumer Electronics Show (CES), Eyenovia showcased its Microdose Array Print (MAP™) Technology, the first significant advancement in ocular drug...

Via Newswire.com

Eyenovia's Optejet Shows Lower Proinflammatory Cytokines Levels, Chemokines Than Standard Drops ↗

January 12, 2023

Via Benzinga

Recap: Eyenovia Q2 Earnings ↗

August 10, 2022

Eyenovia (NASDAQ:EYEN) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 12, 2023

Via Benzinga

Eyenovia Aims to Revolutionize Ophthalmology Devices With Microdose Array Print (MAP) Technology

December 22, 2022

The Microdose Array Print (MAP) Technology has shown potential in clinical trials, providing the possibility of more accurate ocular drug delivery than traditional eye droppers

Via Newswire.com

Earnings Outlook For Eyenovia ↗

November 09, 2022

Eyenovia (NASDAQ:EYEN) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. Analysts estimate that Eyenovia will...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 20, 2022

Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock increased by 45.5% to $1.76 during Thursday's pre-market session. The market value of their outstanding shares is at $96.2 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

October 17, 2022

Good morning, investor! It's time to start off the trading week with a breakdown of the biggest pre-market stock movers on Monday!

Via InvestorPlace

Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket ↗

October 17, 2022

Gainers

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2022 ↗

October 05, 2022

Upgrades

Via Benzinga

Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday ↗

September 09, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 01, 2022

Via Benzinga

Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday ↗

September 02, 2022

Gainers

Via Benzinga

Eyenovia's Novel Optejet® Dispenser Puts People's Eyes First

August 30, 2022

While traditional eye drop bottles require hand-eye coordination and deliver four to five times more medication than the human eye can hold, the Optejet® dispenser's human-centric design administers an...

Via Newswire.com

Stocks That Hit 52-Week Lows On Thursday ↗

August 25, 2022

On Thursday, 63 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 24, 2022

Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) shares moved upwards by 20.1% to $1.79 during Wednesday's after-market session. The market value of their outstanding shares is at $31.6 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 10, 2022

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.